Effect of enzalutamide dose reduction on fatigue, cognition, and drug trough levels in patients with prostate cancer
Phase 2
- Conditions
- Prostate Cancer
- Registration Number
- ACTRN12617000616370
- Lead Sponsor
- Macquarie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- 47
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method